Study Comparing Bioavailability of Oral Formulations of Vabicaserin

Wyeth

Status and phase: Completed; Phase 1

Conditions: Schizophrenia

Treatments: Drug: vabicaserin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00541996

3153A1-1116

Details and patient eligibility

About

The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.

Sex: Male

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy men aged 18-50 years.

Exclusion criteria

• Any significant disease state.
• History of drug or alcohol abuse within 1 year.
• Abnormal liver function tests.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)